CASCADES INC.
2016 Industrial & Construction Conference
May 11, 2016
CASCADES INC. 2016 Industrial & Construction Conference May - - PowerPoint PPT Presentation
CASCADES INC. 2016 Industrial & Construction Conference May 11, 2016 DISCLAIMER Certain statements in this presentation, including statements regarding future results and performance, are forward-looking statements within the meaning of
CASCADES INC.
2016 Industrial & Construction Conference
May 11, 2016
DISCLAIMER
2
Certain statements in this presentation, including statements regarding future results and performance, are forward-looking statements within the meaning of securities legislation based on current expectations. The accuracy of such statements is subject to a number of risks, uncertainties and assumptions that may cause actual results to differ materially from those projected, including, but not limited to, the effect of general economic conditions, decreases in demand for Cascades Inc.’s (“Cascades,” “CAS,” the “Company,” the “Corporation,” “us” or “we”) products, the prices and availability of raw materials, changes in the relative values of certain currencies, fluctuations in selling prices and adverse changes in general market and industry conditions. This presentation may also include price indices as well as variance and sensitivity analyses that are intended to provide the reader with a better understanding of the trends related to our business activities. These items are based
The financial information included in this presentation also contains certain data that are not measures of performance under IFRS (“non-IFRS measures”). For example, the Company uses operating income before depreciation and amortization (“OIBD” which, for purposes of this presentation, we call “EBITDA”) and operating income before depreciation and amortization (excluding specific items) (“OIBD (excluding specific items)” which, for purposes of this presentation, we call “EBITDA (excluding specific items)”) because such measures are used by management to assess the operating and financial performance of the Company’s operating segments. Such information is reconciled to the most directly comparable financial measures, as set forth in the “Supplemental Information on Non-IFRS Measures” section of our most recent quarterly report or annual report. Specific items are defined as items such as charges for or reversal of impairment of assets, for facility or machine closures, accelerated depreciation of assets due to restructuring measures, premiums paid on long-term debt refinancing, loss on refinancing of long-term debt, gains or losses on sales of business units, unrealized gains or losses on derivative financial instruments that do not qualify for hedge accounting, unrealized gains or losses on interest rate swaps, foreign exchange gains
discontinued operations or in the share of results of our associates and joint ventures. All amounts in this presentation are in Canadian dollars unless otherwise indicated.
33% 32% 20% 15% Containerboard Tissue Papers Boxboard Europe Specialty Products
Segment Sales Breakdown1
COMPANY OVERVIEW
3
headquartered in Kingsey Falls, QC
tissue products principally composed of recycled fibre
segments: Tissue and Containerboard
product offerings
entrepreneurial philosophy
LTM 3/31/16 Net Sales $3,954 million
47% 27% 13% 13% Containerboard Tissue Papers Boxboard Europe Specialty Products
Segment EBITDA Breakdown1, 2
LTM 3/31/16 EBITDA $447 million
COMPANY OVERVIEW
Leading Packaging and Tissue Paper Manufacturer
4
Packaging Products
Containerboard
Tissue Papers
Boxboard Europe Specialty Products
Market Position
leaders
boxboard in Europe
Canada
LTM 3/31/16 Financials
5
23% Europe Canada 50% US 27% 23% Europe Canada 37% US 40% 9% Europe Canada 60% US 31% 19% Europe Canada 52% US 29%
Sales from (in %) Sales to (in %) Operating Units (in %) PP&E by Geographic Segment (in %)
Note: Figures as of December 31, 2015
COMPANY OVERVIEW
Sales and Operations Across North America and Europe
6
GEOGRAPHICALLY DIVERSIFIED
COMPANY OVERVIEW
Closed-loop Business Model
7
Upstream and downstream integration in North America
80% recycled fibre (2.6M tons) NA integration rate (2015): 28% (0.44M tons) NA integration rate (2015)
64%
67%
CLIENTS
1 Integration rate for our containerboard activities in North America (considering 100% of Greenpac’s production as internal capacity) 2 Including Reno De Medici’s units and Greenpac. Also including four manufacturing/converting tissue papers units which are counted in both Converting and Manufacturing.Recovery
Manufacturing2
6 units
6 units
3 units
11 units 26 units
Converting2
18 units
17 units
13 units 48 units
Finished Products
recycling centers
1 2 3 4 5 6
Contractual Agreements 23% Regular and Steady Volume (Noncontractual) 27% Recovery & Internal 25% Spot 25%
RAW MATERIALS
Reliable Sourcing Strategy
8
20151
Most of the fibre supply coming from internal sources, contracts and regular streams
Top Recovered Paper Suppliers in the World Cascades’ North American Recycled Fibre Supply Our Strategy
increase tons under control
(M Tonnes)
Source: RISI
segments
circumstances
285 342 340 426 447 6.0% 8.0% 10.0% 12.0% 14.0% 16.0% 18.0% 200 250 300 350 400 450 500 2012 2013 2014 2015 LTM 3/31/16 3,141 3,370 3,561 3,861 3,954 2,750 3,000 3,250 3,500 3,750 4,000 4,250 2012 2013 2014 2015 LTM 3/31/16
OPERATING PERFORMANCE AND FINANCIAL SITUATION
Strong Financial Momentum
9
Sales EBITDA (excl. specific items)
(M CAN$) (M CAN$)
Improved results reflect improved productivity, FX and stable raw material & energy costs
138 133 96 119 138 0% 20% 40% 60% 80% 100% 25 50 75 100 125 150 2012 2013 2014 2015 LTM 3/31/16 37 41 40 58 62 0% 20% 40% 60% 80% 100% 20 40 60 80 100 2012 2013 2014 2015 LTM 3/31/16 43 57 72 63 62 0% 20% 40% 60% 80% 100% 20 40 60 80 100 2012 2013 2014 2015 LTM 3/31/16 90 150 164 231 234 0% 20% 40% 60% 80% 100% 50 100 150 200 250 300 2012 2013 2014 2015 LTM 3/31/16
OPERATING PERFORMANCE AND FINANCIAL SITUATION
Historical Segmented EBITDA
10
Containerboard Boxboard Europe Specialty Products Tissue Papers
(M CAN$) (M CAN$)
Green line represents segment EBITDA as percent of total Company EBITDA; EBITDA excluding specific items
(M CAN$) (M CAN$)
(0.28) 0.78 0.86 1.58 1.60 (0.50) 0.00 0.50 1.00 1.50 2.00 2012 2013 2014 2015 LTM 3/31/16 155 233 277 337 358 100 200 300 400 2012 2013 2014 2015 LTM 3/31/16
1 Excluding specific items 2 Excluding increase in investments11
Objective of ~$100M of free cash flow annually directed toward debt reduction
OPERATING PERFORMANCE AND FINANCIAL SITUATION
Cash Flow and Free Cash Flow per Share
Free Cash Flow per Share1,2 Cash Flow From Operating Activities1
since 2012
Action Plan
(M CAN$) (CAN$)
184 161 184 173 185 100 150 200 2012 2013 2014 2015 2016B
OPERATING PERFORMANCE AND FINANCIAL SITUATION
Capital Expenditures
12
Capital Expenditures
funded capital expenditures
(M CAN$)
including IT
Capex Distribution for FY2015 – $173M
Specialty Products Containerboard 37% Tissue Papers 33% 13% 8% 9% Corporate Boxboard Europe
OPERATING PERFORMANCE AND FINANCIAL SITUATION
Debt Maturities
13
Refinancings in 2014 and 2015 resulting in +US$20 million interest savings
senior notes refinanced
2022 and 2023
extended to 2019
to 4.93% in 2015 from 6.05% in 2013
~$23 million annually
33 132 282 250 714 325 250 500 750 1,000 1 year > 1 year 2019 2021 2022 2023 Debts without recourse Subsidiaries debts Revolver Senior notes
Debt Repayment as at March 31, 2016
14
BUSINESS SEGMENT HIGHLIGHTS
Attractive Containerboard Market Conditions with Greenpac Investment Delivering Results Strong Position Across the North American Tissue Market Boxboard Europe Continues to Strengthen with Recent Rationalizations and Asset Improvements Specialty Products Group Provides a Stable Source of Revenue, Unique Platform for Innovation and Hedge for Recovered Paper Price Volatility
60% 70% 80% 90% 100% Q1 2009 Q1 2010 Q1 2011 Q1 2012 Q1 2013 Q1 2014 Q1 2015 Q1 2016
North American Containerboard Producers
40.0 36.0 38.0 42.0 44.0 1.0
2014
39.9 0.7
New capacity
0.9 42.2
New capacity 2018e
43.1
New capacity 2017e
0.6 40.9
New capacity 2016e
41.5
2015e
CONTAINERBOARD
Environment Still Sound
15
Fundamentals Sound Despite Added Capacity
Operating Rates and Expected Capacity
(Million s.t.)
% of total capacity
IP 33%
WestRock 19%
GP 10%
PCA 10%
Kapstone 4%
Cascades 4%
Pratt 4% Others 16% Top-5 Producers 76% 2015 Industry Participants
Source: RISI, Deutsche Bank, Company reports and estimates
1 Including 59.7% of Greenpac’s total capacity2 SP Fiber PCA D3 Yr 2 Pratt Yr 1 Greif Yr 1 IP Valliant Yr 1
Productivity 1% Pratt Yr 2 Greif Yr 2 IP Valliant Yr 2 SP Fiber Yr 2
Productivity 1%
1
(Operating rate)
Kruger Yr 1
Productivity 1% Kruger Yr 1
Productivity 1%
(+2.5%) (+1.5%) (+1.7%) (+2.1%)
CONTAINERBOARD
Our Strategic Move: Greenpac
16
Note: Greenpac is not consolidated in the results and balance sheet since Cascades does not have effective control under IFRS
1,500 s.t./day of lightweight recycled linerboard (26 pounds)
Greenpac XP grades represent 75% of total production in Q1-2016
fund and two independent converters
6% 7% 9% 8% 7% 33 40 48 45 43 10 20 30 40 50 2012 2013 2014 2015 LTM Q1-2016 (M€)
BOXBOARD EUROPE
Stronger and Leaner Production Platform
17
modernization investments have resulted in improved performance
M
Manufacturing – Recycled grades Manufacturing – Virgin grades
M M MM M M M
#2 Producer of Coated Recycled Boxboard in Europe EBITDA & EBITDA Margin
Energy credits totaling €4M in 2013, €6M in 2014
SPECIALTY PRODUCTS GROUP
Stable Source of Revenue and Unique Platform for Innovation
18
Canada
Canada
Recycling and Recovery (~30% of sales1) Consumer Packaging Products (~20% of sales1) Industrial Packaging Products (~45% of sales1)
Other Products (~5% of sales1)
1 Including 100% of joint ventures9,230 9,390 9,570 9,818 10,382 160 180 248 564 2,500 5,000 7,500 10,000 12,500 2009 New capacity 2011 New capacity 2013 New capacity 2015 New capacity 2017e
Branded 56% Private Label 44% At-Home 44% Away-from- Home 39% Parent Rolls 17% Branded 11% Private Label 89%
TISSUE PAPERS
Stong Position Across the North American Tissue Market
19
Source: RISI
Sales by Geography (2015) Sales by End Markets (2015) Tissue Market Demand North American Tissue Capacity Additions
80 100 120 140 160 1996 2000 2004 2008 2012 2016E Indexed U.S. Tissue Demand (M s.t.)
At-Home 58% At-Home 51% Away-from- Home 42% Away-from- Home 49%
Canada (25%) US (75%)
(+1.7%) (+1.9%) (+2.6%) (+5.7%)
TISSUE PAPERS
Extended Geographical Reach
20
2015 NORTH AMERICAN TISSUE MANUFACTURERS Capacity ('000 s.t.) Market Share Capacity Retail Capacity AfH 1 Georgia-Pacific 2,849 29% 67% 33% 2 Procter & Gamble 1,494 15% 100% 0% 3 Kimberly-Clark 1,466 15% 67% 33% 4 SCA Tissue NA 772 8% 0% 100% 5 Cascades Tissue 657 7% 62% 38% 6 Clearwater Paper 435 4% 90% 10% 7 KP Tissue 399 4% 77% 23% 8 First Quality Tissue 290 3% 100% 0% 9 Irving Tissue 282 3% 100% 0% 10 Soundview Paper 161 2% 67% 33% Others 1,012 10% TOTAL 9,818 100%
Source: RISI, Company reports and estimates
POTENTIAL BENEFITS STEMMING FROM OUR INITIATIVES
21
Other sources of growth and incremental value
Modernizing our operating platform to increase profitability
Potential tailwinds
Taking the right steps to position Cascades for the future
22
For more information:
www.cascades.com/investors Jennifer Aitken, MBA Director, Investor Relations 514-282-2697 or investor@cascades.com